|
I've been following the vaccine trials with interest, because I am both Her2+++, as well as testing positing for the A2 allele.
One thing I'm not clear about--Is the immune response that happens to a "responder" in the vaccine trials, similar to the response a patient has with herceptin?
What I mean is that will the vaccines ultimately need to be part of a treatment plan, being administered once a month indefinitely, the same as Herceptin, in order to maintain the response?
And if that is the fact, then is the ultimate benefit of being in the vaccine trials a temporary response to the treatment, that fades away once you no longer get the vaccine?
|
Threaded Mode